https://www.thebodypro.com/slideshow/this-week-in-hiv-research-renal-upsides-for-tenofovir-alafenamide
Bictegravir/Emtricitabine/Tenofovir Alafenamide (Biktarvy, B/F/TAF)News

This Week in HIV Research: Renal Upsides for Tenofovir Alafenamide

VIEW AS: LIST | SLIDES
glass of milk
Stefan Kühn; licensed under CC BY-SA 3.0

genvoya pills
National Institute of Allergy and Infectious Diseases

E/C/F/TAF Appears Viable for People on Dialysis


Highlighted kidney anatomy
janulla for iStock via Thinkstock

TAF OK in Setting of TDF-Related Renal Injury


illustration of human head with hand thinking a new idea
ARTQU for iStock via Thinkstock

American Indian/Alaska Natives Living With HIV Need More Mental Health Screening


illustration/icon of parent standing with child
Askold Romanov for iStock via Thinkstock

Reproductive Desires Remain Common Among People With HIV


Barbara Jungwirth

Barbara Jungwirth

@bjungwirthNY

Barbara Jungwirth is an experienced freelance journalist, writer, and translator who has been reporting on HIV for TheBody and TheBodyPro since 2002.

Myles Helfand

Myles Helfand

@MylesatTheBody

Myles Helfand is the executive editor and general manager of TheBody/TheBodyPro.